These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 10519590
21. Conservative treatments of intraocular retinoblastoma. Lumbroso-Le Rouic L, Aerts I, Lévy-Gabriel C, Dendale R, Sastre X, Esteve M, Asselain B, Bours D, Doz F, Desjardins L. Ophthalmology; 2008 Aug; 115(8):1405-10, 1410.e1-2. PubMed ID: 18222001 [Abstract] [Full Text] [Related]
22. The International Classification of Retinoblastoma predicts chemoreduction success. Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, Shields JA. Ophthalmology; 2006 Dec; 113(12):2276-80. PubMed ID: 16996605 [Abstract] [Full Text] [Related]
23. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma. Shields CL, Honavar SG, Shields JA, Demirci H, Meadows AT, Naduvilath TJ. Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319 [Abstract] [Full Text] [Related]
25. A phase II trial of carboplatin for intraocular retinoblastoma. Dunkel IJ, Lee TC, Shi W, Beaverson KL, Novetsky D, Lyden D, Finlay JL, McCormick B, Abramson DH. Pediatr Blood Cancer; 2007 Oct 15; 49(5):643-8. PubMed ID: 17301956 [Abstract] [Full Text] [Related]
26. [Diode laser thermotherapy and chemothermotherapy in the treatment of retinoblastoma]. Lumbroso L, Doz F, Levy C, Dendale R, Vedrenne J, Bours D, Zucker JM, Asselain B, Desjardins L. J Fr Ophtalmol; 2003 Feb 15; 26(2):154-9. PubMed ID: 12660589 [Abstract] [Full Text] [Related]
27. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes. Shields CL, Ramasubramanian A, Thangappan A, Hartzell K, Leahey A, Meadows AT, Shields JA. Ophthalmology; 2009 Mar 15; 116(3):544-551.e1. PubMed ID: 19157557 [Abstract] [Full Text] [Related]
28. Orbital fibrosis and intraocular recurrence of retinoblastoma following periocular carboplatin. Kim JW, Yau JW, Moshfeghi D, Fishman M. J Pediatr Ophthalmol Strabismus; 2010 May 21; 47 Online():e1-4. PubMed ID: 21214147 [Abstract] [Full Text] [Related]
29. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients. Shields CL, Shelil A, Cater J, Meadows AT, Shields JA. Arch Ophthalmol; 2003 Nov 21; 121(11):1571-6. PubMed ID: 14609913 [Abstract] [Full Text] [Related]
30. Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation. Chan HS, DeBoer G, Thiessen JJ, Budning A, Kingston JE, O'Brien JM, Koren G, Giesbrecht E, Haddad G, Verjee Z, Hungerford JL, Ling V, Gallie BL. Clin Cancer Res; 1996 Sep 21; 2(9):1499-508. PubMed ID: 9816326 [Abstract] [Full Text] [Related]
31. Sudden dispersion of retinoblastoma shortly after initial chemotherapy treatment. Parness-Yossifon R, Bryar PJ, Weinstein JL, Srikumaran D, Mets MB. Am J Ophthalmol; 2009 May 21; 147(5):903-6. PubMed ID: 19232557 [Abstract] [Full Text] [Related]
32. Pharmacokinetics of systemic versus focal Carboplatin chemotherapy in the rabbit eye: possible implication in the treatment of retinoblastoma. Hayden BC, Jockovich ME, Murray TG, Voigt M, Milne P, Kralinger M, Feuer WJ, Hernandez E, Parel JM. Invest Ophthalmol Vis Sci; 2004 Oct 21; 45(10):3644-9. PubMed ID: 15452072 [Abstract] [Full Text] [Related]
33. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma. Brichard B, De Bruycker JJ, De Potter P, Neven B, Vermylen C, Cornu G. Med Pediatr Oncol; 2002 Jun 21; 38(6):411-5. PubMed ID: 11984802 [Abstract] [Full Text] [Related]
34. Severe pseudo-preseptal cellulitis following sub-Tenon's carboplatin injection for intraocular retinoblastoma. Kiratli H, Kocabeyoğlu S, Bilgiç S. J AAPOS; 2007 Aug 21; 11(4):404-5. PubMed ID: 17306997 [Abstract] [Full Text] [Related]
35. External beam radiation "salvage" therapy in transgenic murine retinoblastoma. Sobrin L, Hayden BC, Murray TG, Cicciarelli N, Scott IU, Hernandez E, Wu X, Markoe AM, Feuer W, Fulton L, O'Brien JM. Arch Ophthalmol; 2004 Feb 21; 122(2):251-7. PubMed ID: 14769602 [Abstract] [Full Text] [Related]
36. Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results. Shields CL, Manjandavida FP, Arepalli S, Kaliki S, Lally SE, Shields JA. JAMA Ophthalmol; 2014 Mar 21; 132(3):319-25. PubMed ID: 24407202 [Abstract] [Full Text] [Related]
37. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture. Shields CL, Douglass AM, Beggache M, Say EA, Shields JA. Retina; 2016 Jun 21; 36(6):1184-90. PubMed ID: 26630319 [Abstract] [Full Text] [Related]
38. Assessment of hearing in very young children receiving carboplatin for retinoblastoma. Smits C, Swen SJ, Theo Goverts S, Moll AC, Imhof SM, Schouten-van Meeteren AY. Eur J Cancer; 2006 Mar 21; 42(4):492-500. PubMed ID: 16376542 [Abstract] [Full Text] [Related]
39. Anecortave acetate as single and adjuvant therapy in the treatment of retinal tumors of LH(BETA)T(AG) mice. Jockovich ME, Murray TG, Escalona-Benz E, Hernandez E, Feuer W. Invest Ophthalmol Vis Sci; 2006 Apr 21; 47(4):1264-8. PubMed ID: 16565356 [Abstract] [Full Text] [Related]
40. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma. Chantada GL, Dunkel IJ, Antoneli CB, de Dávila MT, Arias V, Beaverson K, Fandiño AC, Chojniak M, Abramson DH. Pediatr Blood Cancer; 2007 Sep 21; 49(3):256-60. PubMed ID: 17029248 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]